🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Tocilizumab

    Shanghai Zhongshan Hospital

    Takayasu Arteritis

    approved mab active

    1 trial

  2. Toripalimab

    Coherus Oncology

    Nasopharyngeal Cancer Recurrent

    approved small molecule active

    1 trial

  3. Toujeo

    Almirall, S.A.

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  4. Trastuzumab Rezetecan

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  5. Trelagliptin

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    2 trials

  6. Trelagliptin

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  7. Triple combination therapy group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  8. USTEKINUMAB, USTEKINUMAB, deucravacitinib

    Bristol-Myers Squibb Australia Pty Ltd

    Moderate to Severe Plaque Psoriasis

    approved small molecule active

    1 trial

  9. Ublituximab

    TG THERAPEUTICS, INC.

    Multiple Sclerosis

    approved mab active

    4 trials

  10. Urapidil Accord 5 mg/ml solución inyectable y para perfusión EFG, Trandate 5mg/ml Solution for Injection, Fenilefrina Altan 0,1 mg/ml solución inyectable y para perfusión.

    The George Institute

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  11. Use of Mitomycin-C (MMC) in trabeculectomy

    AEON Biopharma

    Glaucoma

    approved small molecule completed

    1 trial

  12. Use of an Implantable Loop Recorder

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  13. VAB-7

    The First People's Hospital of Lianyungang

    Helicobacter Pylori

    approved small molecule active

    1 trial

  14. Vabysmo 120 mg/mL solution for injection

    Hoffmann-La Roche

    Neovascular Age-Related Macular Degeneration

    approved small molecule active

    1 trial

  15. Vabysmo 120 mg/mL solution for injection in pre-filled syringe

    The George Institute

    SUBRETINAL HYPERREFLECTIVE MATERIAL

    approved small molecule active

    1 trial

  16. Vedolizumab

    Takeda

    Crohn Disease

    approved small molecule terminated

    4 trials

  17. Vedolizumab

    Takeda

    Moderately to Severely Active Crohn's Disease

    approved mab active

    1 trial

  18. Vedolizumab

    Takeda

    Crohn's Disease

    approved small molecule active

    6 trials

  19. Vedolizumab

    Second Affiliated Hospital of Soochow University

    Ulcerative Colitis (UC)

    approved mab completed

    1 trial

  20. Vedolizumab 300 mg

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial

  21. Vedolizumab IV

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial

  22. Vedolizumab Placebo

    Takeda

    Pouchitis

    approved small molecule completed

    1 trial

  23. Venetoclax

    AbbVie

    Acute Myeloid Leukemia (AML)

    approved small molecule active

    1 trial

  24. Vitamine E-400 complex, Microgynon 30, 0,15 mg/0,03 mg omhulde tabletten

    Disc Medicine

    Migraine

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources